Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Return on Capital Employed (2018 - 2024)

Historic Return on Capital Employed for Solid Biosciences (SLDB) over the last 6 years, with Q3 2024 value amounting to 0.56%.

  • Solid Biosciences' Return on Capital Employed rose 900.0% to 0.56% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.56%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.53% for FY2023, which is 500.0% down from last year.
  • Solid Biosciences' Return on Capital Employed amounted to 0.56% in Q3 2024, which was up 900.0% from 0.44% recorded in Q2 2024.
  • Solid Biosciences' Return on Capital Employed's 5-year high stood at 0.44% during Q2 2024, with a 5-year trough of 2.88% in Q3 2020.
  • In the last 4 years, Solid Biosciences' Return on Capital Employed had a median value of 0.57% in 2023 and averaged 0.92%.
  • Data for Solid Biosciences' Return on Capital Employed shows a peak YoY increase of 1200bps (in 2020) and a maximum YoY decrease of -17500bps (in 2020) over the last 5 years.
  • Over the past 4 years, Solid Biosciences' Return on Capital Employed (Quarter) stood at 1.09% in 2020, then surged by 53bps to 0.51% in 2022, then decreased by -27bps to 0.65% in 2023, then increased by 13bps to 0.56% in 2024.
  • Its Return on Capital Employed stands at 0.56% for Q3 2024, versus 0.44% for Q2 2024 and 0.51% for Q1 2024.